Results for tag: "Kineret"

Kineret is a biopharmaceutical drug used to treat immune disorders, such as rheumatoid arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a recombinant form of human interleukin-1 receptor antagonist (IL-1Ra) and works by blocking the action of interleukin-1, a protein involved in inflammation. Kineret is administered as a subcutaneous injection and is available in both brand-name and generic forms. Kineret is a popular treatment option for immune disorders, as it has been shown to reduce inflammation and improve symptoms. It is also well-tolerated, with few side effects. However, it is not a cure for these conditions and long-term use may be necessary to maintain symptom relief. The Kineret market is highly competitive, with several major players. These include Amgen, Pfizer, AbbVie, and UCB. Other companies, such as Novartis, Merck, and Sanofi, also have a presence in the market. Show Less Read more